Bifidobacterium Breve M-16V supplementation for targeted health support.
Yes. One of the most studied strains in infants, including preterm babies.
Studies show reduced eczema and food allergy risk with early-life supplementation.
Yes. Benefits for digestive health and immune modulation apply to all ages.
Click through to the studies bar for the evidence base.
See the dosing guide below.
Compare formats before buying.
Some ingredients build up over weeks. Others act fast.
The compound effect of consistent dosing.
Check the cautions section if you have a pre-existing condition.
Some ingredients you feel. Others just work in the background.
Yes. It's a Morinaga strain with extensive proprietary research.
Strain matters. M-16V has specific research that other B. breve strains don't.
Reasonably well. Bifidos are more acid-sensitive than some strains but M-16V is selected for survival.
Most research uses 5000000000.0g daily. Below 1000000000.0g, you're probably wasting money. Above 20000000000.0g, no extra benefit. The curve plateaus. Safe upper limit ~ 50000000000.0g.
Bifidobacterium Breve M-16V has emerging evidence.
Originally isolated from healthy infant gut microbiome
Bifidobacterium Breve M-16V interacts with other supplements and meds. The analyzer flags interactions, dose mismatches, and timing collisions across your whole list.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.